Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.

Confluent (NASDAQ:CFLT – Get Free Report) had its target price upped by Evercore ISI from $32.00 to $40.00 in a report ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on McKesson (MCK – Research Report), Biogen (BIIB – ...

Palo Alto Networks (NASDAQ:PANW – Get Free Report)‘s stock had its “hold” rating restated by stock analysts at Westpark ...

Karman Holdings Inc. ("Karman" or the "Company"), a company specializing in the upfront design, testing, manufacturing, and sale of mission-critical systems for existing and emerging missile and ...

Eaton Partners has hired a former Lazard vice-president as the firm continues to bolster its secondaries advisory ...

The Trump trade war has blown past the realm of tariffs. The White House plans to hit back at any measure undertaken by ...

Nvidia Corporation's AI chip dominance remains solid despite DeepSeek's claims. Click for why NVDA's ecosystem, innovation, ...

Presentation Operator Thank you for standing-by. My name is Jeanine and I will be your conference operator for today. At this time, I would like to welcome everyone to the Q4 2024 Earnings Conference ...

Evercore ISI analyst Michael Lonegan lowered the firm’s price target on PG&E to $15 from $20 and keeps an In Line rating on the shares. The ...